expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
the same period of the last year. The decrease was primarily due to a decrease in profits from Joint ventures and associates from the store closure under government measures. 9. Tax expense (income) was
fixed interest rate from 2.05 to 3.01 percent per annum to reduce financial cost and risk management from floating interest rate. As a result, the Company has saved interest expense approximately by Baht
profit in Q4/2020 and 2020 were THB 127 million and THB 468 million, respectively, decreased by 30% from Q4/2019 and 39% from 2019, corresponding to the decrease in sales. • Gross profit margin in Q4/2020
Company”) reported consolidated operating revenue of THB 115 million in Q3/2021 and THB 431 million in 9M/2021, decreased by 42% from Q3/2020 and 23% from 9M/2020, respectively. • The decrease was mainly
same period of the previous year. Expenses analysis Q1 2017 Q1 2018 Increase/(Decrease) THB mm THB mm THB mm % Selling expense 32.9 47.3 14.4 43.8% Administrative expense 293.5 268.0 (25.5) (8.7
outside amounting to Baht 47.8 million. On the other hands, sales of Natural Gas Power Plants decreased by Baht 34.5 million or 6.9% because of decrease in unit rate which is adjusted in line with the
) (2.16) 12.10 6 Financial cost 17.91 4.80 11.60 3.82 6.31 54.40 7 Profit (loss) before income tax (37.98) (10.16) (29.45) (9.69) (8.47) 28.76 8 Income tax (expense) income 2.94 0.79 (0.61) (0.20) 3.55
December 31, 2018 Financial Statement Consolidate financial statement % revenue from sales 2018 2017 increase(decrease) 2018 2017 Revenues from sales 175.66 295.89 (120.23 ) (40.63%) 100.00% 100.00% Cost of
, 2018 Financial Statement Consolidate financial statement % revenue from sales 2018 2017 increase(decrease) 2018 2017 Revenues from sales 175.66 295.89 (120.23 ) (40.63%) 100.00% 100.00% Cost of sales